Medical devices, healthcare technology and the business of care
510(k) clearance · K262473

NEXUS Hip Stem

Microport Orthopedics, Inc. · Decision date Oct 1, 2026

MEDTECHLEDGER EXPLANATIONK262473

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on October 1, 2026 for the NEXUS® Hip Stem, submitted by Microport Orthopedics, Inc. of Arlington, Tennessee, under 510(k) number K262473. The device falls under regulation 888.3353 with classification product code LZO and subsequent product code MEH, in the Orthopedic medical specialty and review panel. The application was received July 17, 2026, was not reviewed by a third party, and was not a combination product. A SESE decision is a 510(k) clearance, not a PMA approval.

The submission's stated purpose, per the October 1, 2026 FDA document, is to expand compatibility with previously 510(k) cleared NextStep Arthropedix femoral head components; the NEXUS stems are described as compatible with previously cleared MicroPort and NextStep Arthropedix femoral head and shell/liner components. The source does not specify which prior clearances are referenced, the testing or data relied upon, or any indications, patient-selection criteria or labeling language, so those details remain unknown here.

No predetermined change control plan was authorized, and no summary statement appears in the supplied data. Whether the expanded component compatibility carries clinical or legal implications beyond the cleared labeling cannot be determined from these records.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Oct 1, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262473
Regulatory pathway
510(k) premarket notification
Product code
LZO
Decision code
SESE
Decision date
Oct 1, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented.

Product code
LZO
FDA device class
2

FDA decision timeline

  1. K262473 received

    Application receipt date recorded by FDA.

  2. K262473 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code LZO

Product / regulatory recordCompanyPathwayDecision dateSource
Medacta International S.A.510(k) clearanceSep 17, 2026FDA
United Orthopedic Corporation510(k) clearanceSep 2, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Microport Orthopedics, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Arlington, TN

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records